Park Jong-Hyeok, Lee Dong-Geun, Hwang Juyoung, Lee Sun-Ho, Eoh Whan, Kim Eun-Sang
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Neurosurgery, Spine Center, The Leon Wiltse Memorial Hospital, Suwon, Korea.
Neurospine. 2018 Jun;15(2):144-153. doi: 10.14245/ns.1836048.024. Epub 2018 Jun 19.
To compare overall survival (OS) in patients with cervical spine metastases between initial radiotherapy followed by surgery and initial surgery followed by radiotherapy.
The medical records of 36 patients with cervical spine metastases from January 2007 to December 2015 were retrospectively analyzed. These patients were divided into 2 groups. Group 1 included patients who underwent initial radiotherapy followed by surgery, while group 2 included patients who underwent initial surgery followed by radiotherapy. Clinical outcomes, OS, OS after cervical spine metastasis, and OS after surgery were analyzed in both groups. We evaluated whether primary tumor type, initial treatment modality, the modified Tomita score, Eastern Cooperative Oncology Group performance status, Karnofsky performance status, Japanese Orthopedic Association (JOA) score, Nurick grade, Frankel classification, and preoperative symptoms were associated with OS after cervical spine metastasis.
Both groups exhibited improvement in the postoperative visual analogue scale, but only group 2 showed a significant improvement in postoperative JOA score (p=0.03). OS did not differ significantly between groups. However, OS after cervical spine metastasis was only 7.0 months (95% confidence interval [CI], 4.8-9.3) in group 1 versus 15.8 months (95% CI, 8.8-24.0) in group 2, which represented a significant difference (p<0.05). Factors related to OS after cervical spine metastasis were primary tumor type, initial treatment modality, and preoperative symptoms (p<0.05). Patients who presented with only preoperative pain had approximately 3 fold longer OS after cervical spine metastasis than patients with preoperative motor weakness, even in group 2 (p<0.05).
Surgical treatment prior to the onset of motor weakness or radiotherapy may be a good decision in case of cervical spine metastasis.
比较颈椎转移瘤患者初始放疗后手术与初始手术后放疗的总生存期(OS)。
回顾性分析2007年1月至2015年12月期间36例颈椎转移瘤患者的病历。这些患者被分为两组。第1组包括初始放疗后手术的患者,而第2组包括初始手术后放疗的患者。分析两组的临床结局、OS、颈椎转移后的OS以及手术后的OS。我们评估了原发肿瘤类型、初始治疗方式、改良Tomita评分、东部肿瘤协作组体能状态、卡氏功能状态、日本矫形外科学会(JOA)评分、Nurick分级、Frankel分级以及术前症状是否与颈椎转移后的OS相关。
两组术后视觉模拟量表评分均有改善,但仅第2组术后JOA评分有显著改善(p = 0.03)。两组间OS无显著差异。然而,第1组颈椎转移后的OS仅为7.0个月(95%置信区间[CI],4.8 - 9.3),而第2组为15.8个月(95% CI,8.8 - 24.0),差异有统计学意义(p<0.05)。与颈椎转移后OS相关的因素有原发肿瘤类型、初始治疗方式和术前症状(p<0.05)。即使在第2组中,仅表现为术前疼痛的患者颈椎转移后的OS比术前有运动无力的患者长约3倍(p<0.05)。
对于颈椎转移瘤患者,在出现运动无力之前进行手术治疗或放疗可能是一个不错的选择。